Yorvipath
168 ug/.56mL · Injection, Solution
- Prescription only
- Parathyroid Hormone Analog
- Active substance
- Palopegteriparatide
- Made by
- Ascendis Pharma, Endocrinology, Inc.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
CanadaNo exact match for this strength and form
Netherlands1 matching products
Details
| Made by | Ascendis Pharma, Endocrinology, Inc. |
|---|---|
| Active substance | Palopegteriparatide |
| Used in | Hormones, such as thyroid and steroids |
| Strength | 168 ug/.56mL |
| Form | Injection, Solution |
| Route | Subcutaneous |
| Packs | 2 BOX in 1 CARTON / 1 SYRINGE in 1 BOX / 1 CARTRIDGE in 1 SYRINGE / .56 mL in 1 CARTRIDGE |
| NDC | 73362-100 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).
Other strengths and forms
3 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- Injection, Solution3 products
- 168 ug/.56mL
- 294 ug/.98mL
- 420 ug/1.4mL
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.